Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Operating Expenses | 1,929 | 2,699 | 3,230 | 2,093 | 1,954 |
| Operating Income | -1,929 | -2,699 | -3,230 | -2,093 | -1,954 |
| Other Income | -783 | 688 | -193 | -228 | 1,616 |
| Pre-tax Income | -2,712 | -2,011 | -3,423 | -2,321 | -338 |
| Income Tax | N/A | 0 | 1 | 2 | N/A |
| Net Income Continuous | -2,712 | -2,011 | -3,424 | -2,323 | -338 |
| Net Income | $-2,712 | $-2,011 | $-3,424 | $-2,323 | $-338 |
| EPS Basic Total Ops | -0.28 | -0.29 | -0.35 | -0.26 | -0.06 |
| EPS Basic Continuous Ops | -0.28 | -0.28 | -0.35 | -0.26 | -0.06 |
| EPS Diluted Total Ops | -0.28 | -0.29 | -0.35 | -0.26 | -0.06 |
| EPS Diluted Continuous Ops | -0.28 | -0.28 | -0.35 | -0.26 | -0.06 |
| EBITDA(a) | $-1,894 | $-2,666 | $-3,201 | $-2,074 | $-1,937 |